Sciomics offers a high-content analysis services for combined phosphorylation / ubiquitinylation and protein analysis to investigate pathway activity, disease mechanisms, drug mode-of-action or discover novel drug targets and biomarkers.
Currently, more than 1,000 proteins, many being keyplayers in biomedical pathways are analysed in parallel by our immuno-based antibody array platform. The platform guarantees robust and reproducible results which can easily be translated in clinical assays.